Doorgaan naar hoofdnavigatie
Doorgaan naar zoeken
Ga verder naar hoofdinhoud
Sorteer per
Keyphrases
Uveitis
100%
Optical Coherence Tomography Angiography (OCT-A)
41%
Optical Coherence Tomography
35%
Adalimumab
31%
Ophthalmologist
23%
Subretinal
21%
Retinal Angiomatous Proliferation
20%
Type 3 Neovascularization
20%
Birdshot
20%
Tuberculosis
20%
Retinal pigment Epithelium
20%
Attenuation Coefficient
20%
B Cells
20%
Quiescence
19%
Non-infectious
18%
Non-infectious Uveitis
18%
Inactive Uveitis
17%
Clinical Manifestations
15%
Retina
15%
Sarcoidosis
14%
Ocular Inflammation
13%
Photodynamic Therapy
13%
Scleritis
12%
Posterior Uveitis
12%
Retinal-choroidal Anastomosis
12%
Retinal Neovascularization
12%
Panuveitis
12%
Spectral Domain Optical Coherence Tomography (SD-OCT)
11%
Intravitreal Bevacizumab
11%
Behet's Disease
11%
Retinal Hemangioblastoma
10%
Angiographic Characteristics
10%
Phase-resolved Doppler
10%
Treatment Effect
10%
OCT Angiography
10%
Short-term Response
10%
QuantiFERON-TB Gold In-Tube
10%
In-tube
10%
Uveitis Etiology
10%
Retinal Degeneration
10%
Change Characteristics
10%
QuantiFERON
10%
Non-endemic
10%
Leukocyte Telomere Length
10%
HLA-A29
10%
Vitreous Proteomics
10%
Retinal Fluid Segmentation
10%
Locally Adaptive
10%
Recombinant Tissue Plasminogen Activator (rt-PA)
10%
Remsima
10%
Medicine and Dentistry
Optical Coherence Tomography
47%
Optical Coherence Tomography Angiography
44%
Uveitis
21%
Bevacizumab
19%
Sarcoidosis
17%
Blood Flow
15%
Photodynamic Therapy
13%
Disease
13%
Surgical Anastomosis
13%
Angiography
12%
Coherence
10%
Treatment Effect
10%
Retinal Pigment Epithelium
10%
QuantiFERON
10%
Neurodegeneration
10%
Maturation
10%
Alteplase
10%
Subretinal Drug Administration
10%
Hemangioblastoma
10%
Recurrent Disease
10%
Infliximab
10%
Disease Activity
10%
Age Related Macular Degeneration
10%
Diabetic Retinopathy
10%
Bleeding
10%
B Cell
10%
Prospective Study
10%
Diabetes Mellitus
10%
Observational Study
10%
Capillary
9%
Retinal Detachment
8%
Volunteer
8%
Choroiditis
5%
Vasculitis
5%
Choroidal Neovascularization
5%
Retina Neovascularization
5%
Immunology and Microbiology
Uveitis
97%
Adalimumab
31%
Sarcoidosis
22%
B Cell
20%
Optics
20%
Scleritis
13%
Photodynamics
10%
Neovascularization (Pathology)
10%
Bevacizumab
10%
Infliximab
10%
Telomere Length
10%
Leukocyte
10%
Rituximab
10%
Mycobacterium Tuberculosis
10%
interferon
10%
Maturation
10%
Normal Human
8%
Capillary
6%
Vasculitis
5%
Lymphadenopathy
5%
